Island Pharmaceuticals Ltd (ILA) - Total Liabilities

Latest as of June 2025: AU$336.43K AUD ≈ $238.04K USD

Based on the latest financial reports, Island Pharmaceuticals Ltd (ILA) has total liabilities worth AU$336.43K AUD (≈ $238.04K USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore ILA operating cash flow to assess how effectively this company generates cash.

Island Pharmaceuticals Ltd - Total Liabilities Trend (2019–2024)

This chart illustrates how Island Pharmaceuticals Ltd's total liabilities have evolved over time, based on quarterly financial data. See Island Pharmaceuticals Ltd (ILA) shareholders funds for net asset value and shareholders' equity analysis.

Island Pharmaceuticals Ltd Competitors by Total Liabilities

The table below lists competitors of Island Pharmaceuticals Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Huikwang TWO:6508	Taiwan	NT$378.89 Million
Sekar Bumi Tbk JK:SKBM	Indonesia	Rp1.06 Trillion
Dynamic Medical Technologies TWO:4138	Taiwan	NT$1.23 Billion
Orexo AB ST:ORX	Sweden	Skr812.20 Million
Oswal Agro Mills Limited NSE:OSWALAGRO	India	Rs58.98 Million
Gateway Real Estate AG XETRA:GTY	Germany	€1.18 Billion
FALCON METALS LTD F:E47	Germany	€883.21K
Drb Holding KO:004840	Korea	₩419.67 Billion

Liability Composition Analysis (2019–2024)

This chart breaks down Island Pharmaceuticals Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Island Pharmaceuticals Ltd stock valuation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	22.27	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.05	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.04	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Island Pharmaceuticals Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Island Pharmaceuticals Ltd (2019–2024)

The table below shows the annual total liabilities of Island Pharmaceuticals Ltd from 2019 to 2024.

Year	Total Liabilities	Change
2024-12-31	AU$336.43K ≈ $238.04K	-67.83%
2023-12-31	AU$1.05 Million ≈ $739.85K	+296.30%
2022-12-31	AU$263.85K ≈ $186.69K	-54.57%
2021-12-31	AU$580.73K ≈ $410.91K	+145.21%
2020-12-31	AU$236.83K ≈ $167.57K	+35037.98%
2019-12-31	AU$674.00 ≈ $476.90	--

About Island Pharmaceuticals Ltd

AU:ILA Australia Biotechnology

Market Cap

$70.44 Million

AU$99.55 Million AUD

Market Cap Rank

#20535 Global

#708 in Australia

Share Price

AU$0.37

Change (1 day)

-1.33%

52-Week Range

AU$0.13 - AU$0.57

All Time High

AU$0.57